STAGE III SPLENIC MARGINAL ZONE LYMPHOMA

Clinical trials for STAGE III SPLENIC MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE III SPLENIC MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for STAGE III SPLENIC MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo aims to control Slow-Growing blood cancer without chemotherapy

Disease control Ongoing

This study is testing how well two targeted drugs, obinutuzumab and ibrutinib, work together as the first treatment for people with certain slow-growing types of non-Hodgkin's lymphoma. The goal is to control the cancer by stopping cancer cells from growing and spreading, potenti…

Matched conditions: STAGE III SPLENIC MARGINAL ZONE LYMPHOMA

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

STAGE III SPLENIC MARGINAL ZONE LYMPHOMA

Get alerted when new STAGE III SPLENIC MARGINAL ZONE LYMPHOMA trials appear

New drug duo aims to control Slow-Growing blood cancer without chemotherapy